The company partnered with local Area Development Partnership to open its new headquarters in Hattiesburg, Mississippi

HATTIESBURG, Mississippi—Arden Home Health and Hospice, a hospice and home health services provider, announced the formal opening of its new corporate headquarters located in Hattiesburg, Mississippi. The opening’s celebration, which was held on Friday, Nov. 1, featured a ribbon-cutting ceremony in partnership with the Area Development Partnership (ADP), a private, non-profit organization based in Hattiesburg.

The new work plan will include wheelchair repairs & oxygen Medicare payments

WASHINGTON—The Office of Inspector General (OIG) updated its work plan with two new durable medical equipment, prosthetics/orthotics and supplies-related reviews, the American Association for Homecare wrote in a recent e-newsletter to members. The OIG is part of the U.S. Department of Health and Human Services and is an independent office that reviews the department for fraud, waste and abuse.

Eric Welsh aims to provide for families and children through new marketing & talent acquisition role

DALLAS—Care Options for Kids (COFK), a pediatric specialists provider, announced Eric Welsh as its new chief marketing and talent acquisition officer. Welsh plans to utilize his experience in home health care marketing to continue the company’s growth. 

Robert Scharff appointed as new executive vice president of revenue cycles & intends to support company’s mission

DALLAS—Care Options for Kids (COFK), a pediatric specialists provider, named Robert Scharff as executive vice president (VP) of revenue cycle. An experienced health care operations and revenue cycle management leader, Scharff aims to support the company’s mission and provide care to children and their families.

A Texas doctor received kickbacks for authorizing DME orders that were not legitimately prescribed or needed

WASHINGTON—A Texas doctor was sentenced to 10 years and one month in prison and ordered to pay more than $34 million in restitution for his role in a scheme to defraud Medicare by prescribing durable medical equipment (DME) and cancer genetic testing without seeing, speaking to or otherwise treating patients.